Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging

dc.contributor.authorZafrilla-López, Marina 
dc.contributor.authorAcosta-Díez, Miriam
dc.contributor.authorMitjans Niubó, Marina
dc.contributor.authorGiménez Palomo, Anna
dc.contributor.authorSaiz, Pilar A.
dc.contributor.authorBarrot i Feixat, Carme
dc.contributor.authorJiménez Martínez, Ester
dc.contributor.authorPapiol, Sergi
dc.contributor.authorRuiz, Victoria
dc.contributor.authorGavín, Patrícia
dc.contributor.authorGarcía-Portilla González, María Paz, 1962-
dc.contributor.authorGonzález-Blanco, Leticia
dc.contributor.authorBobes García, Julio
dc.contributor.authorSchulze, Thomas G.
dc.contributor.authorVieta i Pascual, Eduard, 1963-
dc.contributor.authorBenabarre, Antonio
dc.contributor.authorArias Sampériz, Bárbara
dc.date.accessioned2026-01-20T11:21:02Z
dc.date.available2026-01-20T11:21:02Z
dc.date.issued2024-04-25
dc.date.updated2026-01-20T11:21:02Z
dc.description.abstractLithium (Li) is the first-line treatment for bipolar disorder (BD) even though only 30 % of BD patients are considered excellent responders. The mechanisms by which Li exerts its action are not clearly understood, but it has been suggested that specific epigenetic mechanisms, such as methylation processes, may play a role. In this regard, DNA methylation patterns can be used to estimate epigenetic age (EpiAge), which is accelerated in BD patients and reversed by Li treatment. Our first aim was to compare the DNA methylation profile in peripheral blood between BD patients categorized as excellent responders to Li (Ex-Rp) and non-responders (N-Rp). Secondly, EpiAge was estimated to detect differential age acceleration between the two groups. A total of 130 differentially methylated positions (DMPs) and 16 differentially methylated regions (DMRs) between Ex-Rp (n = 26) and N-Rp (n = 37) were identified (FDR adjusted p-value < 0.05). We found 122 genes mapping the DMPs and DMRs, nine of which (HOXB6, HOXB3, HOXB-AS3, TENM2, CACNA1B, ANK3, EEF2K, CYP1A1, and SORCS2) had previously been linked to Li response. We found genes related to the GSK3β pathway to be highly represented. Using FUMA, we found enrichment in Gene Ontology Cell Component for the synapse. Gene network analysis highlighted functions related to the cell cycle, nervous system development and function, and gene expression. No significant differences in age acceleration were found between Ex-Rp and N-Rp for any of the epigenetic clocks analysed. Our findings indicate that a specific methylation pattern could determine the response to Li in BD patients. We also found that a significant portion of the differentially methylated genes are closely associated with the GSK3β pathway, reinforcing the role of this system in Li response. Future longitudinal studies with larger samples will help to elucidate the epigenetic mechanisms underlying Li response.
dc.format.extent87 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec748181
dc.identifier.issn0924-977X
dc.identifier.urihttps://hdl.handle.net/2445/225798
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2024.03.010
dc.relation.ispartofEuropean Neuropsychopharmacology, 2024, vol. 85, p. 23-31
dc.relation.urihttps://doi.org/10.1016/j.euroneuro.2024.03.010
dc.rightscc-by-nc-nd (c) Elsevier B.V., 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.classificationTrastorn bipolar
dc.subject.classificationEpigenètica
dc.subject.classificationLiti
dc.subject.otherManic-depressive illness
dc.subject.otherEpigenetics
dc.subject.otherLithium
dc.titleLithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
859770.pdf
Mida:
4.42 MB
Format:
Adobe Portable Document Format